Back to search

Article

Comparison of Efficacy and safety of Tinapeg® vs. Neulastim® to prevent chemotherapy-induced neutropenia in breast cancer patients: randomized, parallel, equivalence, multicentric and Phase III clinical trial study

2023-10-28

Abstract excerpt

<h4>Background: </h4> This study investigated the efficacy and safety of Pegylated recombinant human granulocyte colony-stimulating factor (PEG‐rhGCSF) manufactured by Arya Tina gene company in the preventing chemotherapy-induced neutropenia in breast cancer patients. <h4>Methods: </h4> This study was designed as a parallel, randomized, double- blind, multicenter, and Phase III clinical trial. In this way, patien...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c93087e5-9b00-558d-9e5a-0844f2909d95
DOI
10.21203/rs.3.rs-3404965/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Comparison of Efficacy and safety of Tinapeg® vs. Neulastim® to prevent chemotherapy-induced neutropenia in breast cancer patients: randomized, parallel, equivalence, multicentric and Phase III clinical trial studyDOI 10.21203/rs.3.rs-3404965/v1
RNA-sequencing Reveal the Molecular Mechanism of Moxibustion on Neutrophil Gene Expression Profile During Breast Cancer ChemotherapySemantic proximity
A systematic review and meta-analysis of nab-paclitaxel mono-chemotherapy for metastatic breast cancerSemantic proximity
Infectious Complications of Cyclin-Dependent Kinases 4 and 6 Inhibitors in Patients With Hormone Receptor-Positive Metastatic Breast Cancer: A Systematic Review and Meta-analysisSemantic proximity
Chemotherapy characteristics are important predictors of primary prophylactic CSF administration in older patients with breast cancer.Semantic proximity
ABCG2 genetic variant as a predictor of severe neutropenia in Japanese patients with hormone receptor–positive, HER2-negative advanced breast cancer treated with palbociclib: an exploratory real-world studySemantic proximity
Role of pharmacogenetics on adjuvant chemotherapy-induced neutropenia in Chinese breast cancer patients.Semantic proximity
A Systematic Review and Meta-Analysis of Nab-Paclitaxel Mono-Chemotherapy for Metastatic Breast Cancer.Semantic proximity
Importance of standard precautions to febrile neutropenia prevention in patients with cancer during COVID 19 outbreakSemantic proximity
ABCG2 genetic polymorphism as risk factor for neutropenia in patients with metastatic or advanced hormone receptor -positive, HER2-negative breast cancer treated with palbociclibSemantic proximity
Efficacy and Safety of Bevacizumab-Containing Therapy in Refractory Advanced Breast Cancer：A Retrospective StudySemantic proximity
A Phase I/II Study of Preoperative Letrozole, Everolimus, and Carotuximab in Stage 2 and 3 Hormone Receptor-positive and Her2-negative Breast Cancer.Semantic proximity
Real-world incidence of febrile neutropenia despite primary prophylaxis with pegylated G-CSF: a prospective single centre cohort study from IndiaSemantic proximity
Select a neighboring publication to make it the new centre.